Xcout Intel
Apollo Therapeutics
Apollo Therapeutics is a biopharmaceutical company with headquarters located in Cambridge, United Kingdom, alongside offices in Boston, Massachusetts. The company advances breakthrough science to build a portfolio of innovative therapeutics.
Subscribe to see Apollo Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Apollo Therapeutics at a glance
Apollo Therapeutics is a biotechnology company headquartered in United Kingdom, founded in 2021. It has raised at least $631.5M across the 3 funding rounds on record. Its most recent funding round, Series C, raised $260M in January 2024. Xcout tracks 7 named people at Apollo Therapeutics, including Richard Butt (Chief Scientific Officer).
Apollo Therapeutics leadership
- Richard ButtChief Scientific Officer
- Sanjay AggarwalChief Medical Officer
- Clare BurlesVP, People and Communications
- Joana de Abreu CarvalhoVP, Program Leader
- Malcolm BeggVP, Global Program Leader
- Richard BrownVP, Global Program Leader
1 more named person on record for Apollo Therapeutics, with roles, board committees and tenure — see the full roster →
Apollo Therapeutics funding rounds
At least $631.5M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $260M | 1 named | |
| Series C | $226.5M | 1 named | |
| Financing | $145M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Apollo Therapeutics competitors
A few of Apollo Therapeutics's closest competitors — see the full list of competitors and alternatives →
Artios Pharma is an independent biotechnology company headquartered at the Babraham Research Campus in Cambridge, United Kingdom, focused on discovering novel cancer therapies through DNA damage response mechanisms.
Aurora Therapeutics is a biotechnology research company headquartered in Cambridge, Massachusetts. The firm focuses on advanced biomedical research and therapeutic development within the life sciences sector.
NextPoint Therapeutics is a private biopharmaceutical and technology company based in Cambridge, Massachusetts, focused on expanding novel therapeutic possibilities.
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Delphia Therapeutics is a biotechnology research company headquartered in Cambridge, Massachusetts, with a team of 11 to 50 employees focused on therapeutic innovations.
Apogee Therapeutics is a biotechnology company focused on the development of therapies for inflammatory and immunology diseases. The company is headquartered in Waltham, Massachusetts.
Get Apollo Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Apollo Therapeutics in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access